SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Univec (UNVC)
UNVC 0.003100.0%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Phyco who started this subject1/7/2002 1:06:34 PM
From: scott_jiminez   of 181
 
Monday January 7, 8:41 am Eastern Time

Press Release

SOURCE: Univec, Inc.

UNIVEC Acquires Physician and Pharmaceutical Services, Inc.

FARMINGDALE, N.Y.--(BUSINESS WIRE)--Jan. 7, 2002--Farmingdale -based Univec, Inc. (OTCBB: UNVC - news) a leading manufacturer of patented auto-disable and safety syringes, today announced the acquisition of Physician and Pharmaceutical Services, Inc. (PPSI) of Baltimore, Md., a leader in the $8 billion drug sampling market.

PPSI's founder, Dr. David L. Dalton has assumed the position of President and CEO of Univec. Dr. Dalton has over 35 years experience in the healthcare industry, including 18 years with Rite-Aid where he was Corporate Vice President. In addition to PPSI, Dr. Dalton also founded Health Resources, Inc., and Pharmacy Services, Inc.

Dr. Dalton will focus on building Univec's presence in U.S. markets. According to Dr. Dalton, ``We intend to continue Univec's leadership position in the design and manufacture of safe health products by aggressively expanding our distribution and product portfolio.'' Joel Schoenfeld, founder and Chairman of Univec, will continue as Chairman and will focus on Univec's international and government sectors.

<abridged>

biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext